Literature DB >> 27848119

Advanced magnetic resonance imaging of neurodegenerative diseases.

Federica Agosta1, Sebastiano Galantucci1, Massimo Filippi2,3.   

Abstract

Magnetic resonance imaging (MRI) is playing an increasingly important role in the study of neurodegenerative diseases, delineating the structural and functional alterations determined by these conditions. Advanced MRI techniques are of special interest for their potential to characterize the signature of each neurodegenerative condition and aid both the diagnostic process and the monitoring of disease progression. This aspect will become crucial when disease-modifying (personalized) therapies will be established. MRI techniques are very diverse and go from the visual inspection of MRI scans to more complex approaches, such as manual and automatic volume measurements, diffusion tensor MRI, and functional MRI. All these techniques allow us to investigate the different features of neurodegeneration. In this review, we summarize the most recent advances concerning the use of MRI in some of the most important neurodegenerative conditions, putting an emphasis on the advanced techniques.

Entities:  

Keywords:  Alzheimer’s disease; Atrophy; Dementia with Lewy bodies; Diffusion tensor MRI; Frontotemporal dementia; Magnetic resonance imaging; Parkinson’s disease; Primary progressive aphasia; Resting state functional MRI

Mesh:

Year:  2016        PMID: 27848119     DOI: 10.1007/s10072-016-2764-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  77 in total

1.  Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND.

Authors:  Prashanthi Vemuri; Gyorgy Simon; Kejal Kantarci; Jennifer L Whitwell; Matthew L Senjem; Scott A Przybelski; Jeffrey L Gunter; Keith A Josephs; David S Knopman; Bradley F Boeve; Tanis J Ferman; Dennis W Dickson; Joseph E Parisi; Ronald C Petersen; Clifford R Jack
Journal:  Neuroimage       Date:  2010-12-31       Impact factor: 6.556

2.  White matter damage in frontotemporal lobar degeneration spectrum.

Authors:  F Agosta; E Scola; E Canu; A Marcone; G Magnani; L Sarro; M Copetti; F Caso; C Cerami; G Comi; S F Cappa; A Falini; M Filippi
Journal:  Cereb Cortex       Date:  2011-10-10       Impact factor: 5.357

3.  Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease.

Authors:  Marianna Amboni; Alessandro Tessitore; Fabrizio Esposito; Gabriella Santangelo; Marina Picillo; Carmine Vitale; Alfonso Giordano; Roberto Erro; Rosa de Micco; Daniele Corbo; Gioacchino Tedeschi; Paolo Barone
Journal:  J Neurol       Date:  2014-11-27       Impact factor: 4.849

4.  Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.

Authors:  An-Tao Du; Norbert Schuff; Joel H Kramer; Howard J Rosen; Maria Luisa Gorno-Tempini; Katherine Rankin; Bruce L Miller; Michael W Weiner
Journal:  Brain       Date:  2007-03-12       Impact factor: 13.501

5.  Abnormal network connectivity in frontotemporal dementia: evidence for prefrontal isolation.

Authors:  Norman A S Farb; Cheryl L Grady; Stephen Strother; David F Tang-Wai; Mario Masellis; Sandra Black; Morris Freedman; Bruce G Pollock; Karen L Campbell; Lynn Hasher; Tiffany W Chow
Journal:  Cortex       Date:  2012-09-24       Impact factor: 4.027

6.  Microstructural white matter changes in cognitively normal individuals at risk of amnestic MCI.

Authors:  Lin Zhuang; Perminder S Sachdev; Julian N Trollor; Nicole A Kochan; Simone Reppermund; Henry Brodaty; Wei Wen
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

7.  Lewy body compared with Alzheimer dementia is associated with decreased functional connectivity in resting state networks.

Authors:  Eva R Lowther; John T O'Brien; Michael J Firbank; Andrew M Blamire
Journal:  Psychiatry Res       Date:  2014-06-27       Impact factor: 3.222

8.  Cortical thinning associated with mild cognitive impairment in Parkinson's disease.

Authors:  Bàrbara Segura; Hugo César Baggio; Maria Josep Marti; Francesc Valldeoriola; Yaroslau Compta; Anna Isabel Garcia-Diaz; Pere Vendrell; Núria Bargallo; Eduardo Tolosa; Carme Junque
Journal:  Mov Disord       Date:  2014-08-07       Impact factor: 10.338

9.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

Authors:  Emma J Burton; Ian G McKeith; David J Burn; E David Williams; John T O'Brien
Journal:  Brain       Date:  2004-01-28       Impact factor: 13.501

10.  L-DOPA changes spontaneous low-frequency BOLD signal oscillations in Parkinson's disease: a resting state fMRI study.

Authors:  Y Kwak; S J Peltier; N I Bohnen; M L T M Müller; P Dayalu; R D Seidler
Journal:  Front Syst Neurosci       Date:  2012-07-04
View more
  14 in total

1.  White matter microstructure in fetal alcohol spectrum disorders: A systematic review of diffusion tensor imaging studies.

Authors:  Farzaneh Ghazi Sherbaf; Mohammad Hadi Aarabi; Meisam Hosein Yazdi; Maryam Haghshomar
Journal:  Hum Brain Mapp       Date:  2018-10-05       Impact factor: 5.038

2.  White matter alterations in early Parkinson's disease: role of motor symptom lateralization.

Authors:  Laura Pelizzari; Sonia Di Tella; Maria M Laganà; Niels Bergsland; Federica Rossetto; Raffaello Nemni; Francesca Baglio
Journal:  Neurol Sci       Date:  2019-10-24       Impact factor: 3.307

Review 3.  Resting-state Functional MRI in Parkinsonian Syndromes.

Authors:  Massimo Filippi; Elisabetta Sarasso; Federica Agosta
Journal:  Mov Disord Clin Pract       Date:  2019-02-08

4.  Determining the number of states in dynamic functional connectivity using cluster validity indexes.

Authors:  Victor M Vergara; Mustafa Salman; Anees Abrol; Flor A Espinoza; Vince D Calhoun
Journal:  J Neurosci Methods       Date:  2020-02-25       Impact factor: 2.390

5.  Detection of memory- and learning-related brain connectivity changes following trace eyeblink-conditioning using resting-state functional magnetic resonance imaging in the awake rabbit.

Authors:  Nicola Bertolino; Daniele Procissi; John F Disterhoft; Craig Weiss
Journal:  J Comp Neurol       Date:  2020-09-30       Impact factor: 3.215

Review 6.  Multiparametric magnetic resonance imaging and positron emission tomography findings in neurodegenerative diseases: Current status and future directions.

Authors:  Neetu Soni; Manish Ora; Girish Bathla; Chandana Nagaraj; Laura L Boles Ponto; Michael M Graham; Jitender Saini; Yusuf Menda
Journal:  Neuroradiol J       Date:  2021-03-05

Review 7.  Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease.

Authors:  Anders Wallin; Gustavo C Román; Margaret Esiri; Petronella Kettunen; Johan Svensson; George P Paraskevas; Elisabeth Kapaki
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  A Machine Learning Approach for the Differential Diagnosis of Alzheimer and Vascular Dementia Fed by MRI Selected Features.

Authors:  Gloria Castellazzi; Maria Giovanna Cuzzoni; Matteo Cotta Ramusino; Daniele Martinelli; Federica Denaro; Antonio Ricciardi; Paolo Vitali; Nicoletta Anzalone; Sara Bernini; Fulvia Palesi; Elena Sinforiani; Alfredo Costa; Giuseppe Micieli; Egidio D'Angelo; Giovanni Magenes; Claudia A M Gandini Wheeler-Kingshott
Journal:  Front Neuroinform       Date:  2020-06-11       Impact factor: 4.081

Review 9.  Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment: a critical review.

Authors:  Elisa Canu; Elisabetta Sarasso; Massimo Filippi; Federica Agosta
Journal:  Alzheimers Res Ther       Date:  2018-02-20       Impact factor: 6.982

10.  Gray/White Matter Contrast in Parkinson's Disease.

Authors:  Carme Uribe; Barbara Segura; Hugo C Baggio; Alexandra Abos; Anna I Garcia-Diaz; Anna Campabadal; Maria J Marti; Francesc Valldeoriola; Yaroslau Compta; Nuria Bargallo; Carme Junque
Journal:  Front Aging Neurosci       Date:  2018-03-27       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.